missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human CXCL5/ENA-78 Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 5 publications
Marca: R&D Systems MAB254-100
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
CXCL5/ENA-78 Monoclonal specifically detects CXCL5/ENA-78 in Human samples. It is validated for Western Blot, Immunohistochemistry, Neutralization.
Especificaciones
| CXCL5/ENA-78 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| chemokine (C-C motif) ligand 5, C-X-C motif chemokine 5, CXCL5, ENA78, ENA-78, ENA-78(1-78), Epithelial-derived neutrophil-activating protein 78, Neutrophil-activating peptide ENA-78, neutrophil-activating protein 78, SCYB5ENA78 | |
| Mouse | |
| Protein A or G purified from ascites | |
| RUO | |
| 6374 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
| Western Blot, Immunohistochemistry, Neutralization | |
| 33160 | |
| Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Neutralization 3-15 ug/mL | |
| P42830 | |
| CXCL5 | |
| E. coli-derived recombinant human CXCL5/ENA-78 Ala37-Asn114 (predicted) Accession # P42830 | |
| 100 μg | |
| Primary | |
| Detects human CXCL5/ENA-78 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) CXCL1, 2, 3, 8, 10, or recombinant mouse CXCL2 is observed. | |
| Human | |
| Ascites |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
For Research Use Only
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido